                         SEQUENCE LISTING

<110>  ASSISTANCE PUBLIQUE HPITAUX DE PARIS
       ALTEVAX
 
<120>  OPTIMIZATION OF PEPTIDE-MELANIN BINDING

<130>  BRV 160 - WO

<150>  EP20305173.5
<151>  2020-02-21

<160>  35    

<170>  PatentIn version 3.5

<210>  1
<211>  9
<212>  PRT
<213>  Artificial

<220>
<223>  gp100 peptide

<400>  1

Lys Val Pro Arg Asn Gln Asp Trp Leu 
1               5                   


<210>  2
<211>  9
<212>  PRT
<213>  Artificial

<220>
<223>  EphA2 peptide

<400>  2

Phe Ser His His Asn Ile Ile Arg Leu 
1               5                   


<210>  3
<211>  8
<212>  PRT
<213>  Artificial

<220>
<223>  test peptide

<400>  3

Ser Ile Tyr Arg Tyr Tyr Gly Leu 
1               5               


<210>  4
<211>  9
<212>  PRT
<213>  Artificial

<220>
<223>  Modified test peptide


<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  ACETYL-ARGININE

<400>  4

Arg Ser Ile Tyr Arg Tyr Tyr Gly Leu 
1               5                   


<210>  5
<211>  9
<212>  PRT
<213>  Artificial

<220>
<223>  Modified test peptide

<400>  5

Pro Ser Ile Tyr Arg Tyr Tyr Gly Leu 
1               5                   


<210>  6
<211>  9
<212>  PRT
<213>  Artificial

<220>
<223>  Modified test peptide


<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  HYDROXY-PROLINE

<400>  6

Pro Ser Ile Tyr Arg Tyr Tyr Gly Leu 
1               5                   


<210>  7
<211>  9
<212>  PRT
<213>  Artificial

<220>
<223>  Modified test peptide


<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  ACETYL-LYSINE

<400>  7

Lys Ser Ile Tyr Arg Tyr Tyr Gly Leu 
1               5                   


<210>  8
<211>  10
<212>  PRT
<213>  Artificial

<220>
<223>  Modified test peptide


<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  ACETYL-ARGININE

<400>  8

Arg Cys Ser Ile Tyr Arg Tyr Tyr Gly Leu 
1               5                   10  


<210>  9
<211>  10
<212>  PRT
<213>  Artificial

<220>
<223>  Modified test peptide


<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  ACETYL-ARGININE

<400>  9

Arg His Ser Ile Tyr Arg Tyr Tyr Gly Leu 
1               5                   10  


<210>  10
<211>  10
<212>  PRT
<213>  Artificial

<220>
<223>  Modified test peptide


<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  ACETYL-ARGININE

<400>  10

Arg Ser Ser Ile Tyr Arg Tyr Tyr Gly Leu 
1               5                   10  


<210>  11
<211>  10
<212>  PRT
<213>  Artificial

<220>
<223>  Modified test peptide


<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  ACETYL-ARGININE

<400>  11

Arg Met Ser Ile Tyr Arg Tyr Tyr Gly Leu 
1               5                   10  


<210>  12
<211>  10
<212>  PRT
<213>  Artificial

<220>
<223>  Modified test peptide


<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  ACETYL-ARGININE

<400>  12

Arg Thr Ser Ile Tyr Arg Tyr Tyr Gly Leu 
1               5                   10  


<210>  13
<211>  10
<212>  PRT
<213>  Artificial

<220>
<223>  Modified test peptide


<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  ACETYL-ARGININE

<400>  13

Arg Phe Ser Ile Tyr Arg Tyr Tyr Gly Leu 
1               5                   10  


<210>  14
<211>  10
<212>  PRT
<213>  Artificial

<220>
<223>  Modified test peptide


<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  ACETYL-ARGININE

<400>  14

Arg Trp Ser Ile Tyr Arg Tyr Tyr Gly Leu 
1               5                   10  


<210>  15
<211>  10
<212>  PRT
<213>  Artificial

<220>
<223>  Modified gp100 peptide

<400>  15

Pro Lys Val Pro Arg Asn Gln Asp Trp Leu 
1               5                   10  


<210>  16
<211>  10
<212>  PRT
<213>  Artificial

<220>
<223>  Modified gp100 peptide


<220>
<221>  MOD_RES
<222>  (1)..(1)
<223>  HYDROXY-PROLINE

<400>  16

Pro Lys Val Pro Arg Asn Gln Asp Trp Leu 
1               5                   10  


<210>  17
<211>  10
<212>  PRT
<213>  Artificial

<220>
<223>  Modified gp100 peptide

<400>  17

Cys Lys Val Pro Arg Asn Gln Asp Trp Leu 
1               5                   10  


<210>  18
<211>  10
<212>  PRT
<213>  Artificial

<220>
<223>  Modified gp100 peptide

<400>  18

Met Lys Val Pro Arg Asn Gln Asp Trp Leu 
1               5                   10  


<210>  19
<211>  9
<212>  PRT
<213>  Artificial

<220>
<223>  N-terminus Modified peptide


<220>
<221>  VARIANT
<222>  (1)..(1)
<223>  Xaa IS A  NUCLEOPHILIC AMINO ACID, ESPECIALLY CYSTEINE, PROLINE 
       OR HYDROXYPROLINE

<400>  19

Xaa Val Tyr Asp Phe Phe Val Trp Leu 
1               5                   


<210>  20
<211>  9
<212>  PRT
<213>  Artificial

<220>
<223>  C-terminus Modified peptide


<220>
<221>  VARIANT
<222>  (9)..(9)
<223>  Xaa IS A  NUCLEOPHILIC AMINO ACID, ESPECIALLY CYSTEINE, PROLINE 
       OR HYDROXYPROLINE

<400>  20

Val Tyr Asp Phe Phe Val Trp Leu Xaa 
1               5                   


<210>  21
<211>  26
<212>  DNA
<213>  Artificial

<220>
<223>  Phosphorothioate oligonucleotide CpG-28

<400>  21
taaacgttat aacgttatga cgtcat                                            26


<210>  22
<211>  16
<212>  PRT
<213>  Homo sapiens

<400>  22

Tyr Ala Val Gly Tyr Met Leu Arg Leu Gly Ala Pro Ala Ser Lys Leu 
1               5                   10                  15      


<210>  23
<211>  16
<212>  PRT
<213>  Homo sapiens

<400>  23

Thr Thr Met Asp Gln Lys Ser Leu Trp Ala Gly Val Val Val Leu Leu 
1               5                   10                  15      


<210>  24
<211>  15
<212>  PRT
<213>  Homo sapiens

<400>  24

Lys Ser Val Trp Ser Lys Leu Gln Ser Ile Gly Ile Arg Gln His 
1               5                   10                  15  


<210>  25
<211>  15
<212>  PRT
<213>  Human coronavirus

<400>  25

Tyr Val Gly Tyr Leu Gln Pro Arg Thr Phe Leu Leu Lys Tyr Asn 
1               5                   10                  15  


<210>  26
<211>  11
<212>  PRT
<213>  Human coronavirus

<400>  26

Gly Tyr Leu Gln Pro Arg Thr Phe Leu Leu Lys 
1               5                   10      


<210>  27
<211>  10
<212>  PRT
<213>  Human coronavirus

<400>  27

Lys Val Val Asn Gln Asn Ala Gln Ala Leu 
1               5                   10  


<210>  28
<211>  14
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  PTPRZ1 Epitope

<400>  28

Lys Val Phe Ala Gly Ile Pro Thr Val Ala Ser Asp Thr Val 
1               5                   10                  


<210>  29
<211>  16
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Modified UCP2 Peptide

<400>  29

Cys Lys Ser Val Trp Ser Lys Leu Gln Ser Ile Gly Ile Arg Gln His 
1               5                   10                  15      


<210>  30
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  PTPRZ1 Epitope

<400>  30

Lys Val Phe Ala Gly Ile Pro Thr Val 
1               5                   


<210>  31
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Modified PTPRZ1 Epitope

<400>  31

Cys Lys Val Phe Ala Gly Ile Pro Thr Val 
1               5                   10  


<210>  32
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  PTPRZ1 Epitope

<400>  32

Ala Ile Ile Asp Gly Val Glu Ser Val 
1               5                   


<210>  33
<211>  25
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Peptide with PTPRZ1 and Telomerase Epitopes

<400>  33

Lys Val Phe Ala Gly Ile Pro Thr Val Ser Lys Ser Val Trp Ser Lys 
1               5                   10                  15      


Leu Gln Ser Ile Gly Ile Arg Gln His 
            20                  25  


<210>  34
<211>  15
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Modified PTPRZ1 Epitope

<400>  34

Cys Lys Val Phe Ala Gly Ile Pro Thr Val Ala Ser Asp Thr Val 
1               5                   10                  15  


<210>  35
<211>  26
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Modified Peptide with PTPRZ1 and Telomerase Epitopes

<400>  35

Cys Lys Val Phe Ala Gly Ile Pro Thr Val Ser Lys Ser Val Trp Ser 
1               5                   10                  15      


Lys Leu Gln Ser Ile Gly Ile Arg Gln His 
            20                  25      


